← Back to Search

Behavioral Intervention

Belly-focus concentration meditation for Alzheimer's Disease

N/A

Recruiting

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged between 18-35 years old

Healthy adults who weigh at least 110 pounds

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured from blood draws before and after a one-week intervention

Awards & highlights

Study Summary

This trial will look at how two different types of meditation affect markers for Alzheimer's Disease, emotional well-being, and memory. Healthy adults aged 18-35 will be asked to meditate daily for

Who is the study for?

This trial is for healthy adults aged 18-35, fluent in English, weighing at least 110 pounds. Participants must commit to daily meditation or a control task for one week and provide blood samples.Check my eligibility

What is being tested?

The study tests how belly-focus meditation with slow breathing and regular belly-focus meditation impact Alzheimer's Disease biomarkers, emotional well-being, and memory in young adults.See study design

What are the potential side effects?

Since the interventions are non-invasive forms of meditation, significant side effects are not anticipated. However, individual experiences may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 35 years old.

Select...

I am a healthy adult weighing at least 110 pounds.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured from blood draws before and after a one-week intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured from blood draws before and after a one-week intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured from blood draws before and after a one-week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in plasma Ab42/40 ratio

Change in plasma amyloid beta levels

Secondary outcome measures

Change in emotional well-being

Change in plasma pTau-181/tau ratio

Other outcome measures

Episodic memory

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Belly-focus concentration meditation with slow breathingExperimental Treatment1 Intervention

Participants will engage in concentration meditation and slow breathing for 40 minutes every day for a week while recording heart rate. They will focus on the sensations around the belly while breathing slowly.

Group II: Belly-focus concentration meditationExperimental Treatment1 Intervention

Participants will engage in concentration meditation for 40 minutes every day for a week while recording heart rate. They will focus on the sensations around the belly.

Group III: No-intervention controlActive Control1 Intervention

Participants will rest quietly for 40 minutes every day for a week while recording heart rate.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor

906 Previous Clinical Trials

1,596,095 Total Patients Enrolled

University of California, IrvineOTHER

544 Previous Clinical Trials

1,922,962 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age criterion that would make individuals over 50 years old qualified for this trial?

"Recruitment is open to individuals aged above 18 years and under 35 years old for this clinical trial."

Answered by AI

Are there any available slots for patients to participate in this clinical trial?

"As per the information available on clinicaltrials.gov, this research endeavor is currently in the process of actively seeking eligible participants. The trial was initially listed on 1/29/2024 and underwent its most recent update on 2/20/2024."

Answered by AI

What is the upper limit for patient participation in this medical investigation?

"Indeed, as per the details available on clinicaltrials.gov, this research endeavor is presently accepting new entrants. The commencement date of this study was January 29th, 2024, with the most recent update being recorded on February 20th, 2024. A total of 81 individuals are sought after for enrollment at a single designated site."

Answered by AI

Who meets the criteria to participate in this medical study?

"The investigation seeks 81 individuals aged between 18 to 35 diagnosed with Alzheimer's disease. Eligible candidates must be healthy adults weighing a minimum of 110 pounds, willing to commit 40 minutes daily for a week, proficient in English, agreeable to blood sampling, and fall within the specified age range."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease

Mara Mather 2024. "Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06210035.

All > Alzheimers Disease Anaheim